FluoroquinolonesAdministration, TopicalSkin AbsorptionChemistry, PharmaceuticalSkin Diseases, ViralAnti-Infective AgentsOintmentsAdministration, CutaneousCiprofloxacinOfloxacinSkinDNA GyraseAza CompoundsLevofloxacinMicrobial Sensitivity TestsDNA Topoisomerase IVAnti-Bacterial AgentsNorfloxacinQuinolonesDrug Resistance, BacterialPefloxacinNaphthyridinesQuinolinesEnoxacinDrug Resistance, Microbial4-QuinolonesDrug Resistance, Multiple, BacterialDNA Topoisomerases, Type IIStreptococcus pneumoniaeDermatitis, PhototoxicDrug CompoundingExcipientsDelayed-Action PreparationsTabletsNalidixic AcidTopoisomerase II InhibitorsGram-Negative Bacterial InfectionsDosage FormsMacrolidesDrug CarriersStaphylococcus aureusFleroxacinMycoplasma hominisTechnology, PharmaceuticalPneumococcal Infectionsbeta-LactamsBacterial InfectionsMutationClostridium difficileEscherichia coliEmulsionsDrug StabilityTyphoid FeverMycobacterium fortuitumGram-Negative BacteriaPseudomonas aeruginosaNitrofurantoinAdministration, OralArea Under CurveAminoglycosidesDNA, BacterialTherapeutic EquivalencyCapsulesAntitubercular AgentsGram-Positive BacteriaDrug Resistance, MultipleParticle SizeCapreomycinCommunity-Acquired InfectionsDrug UtilizationBacterial ProteinsUrinary Tract InfectionsPowdersBiological AvailabilityDrug Delivery SystemsEscherichia coli InfectionsSolubilityEnterocolitis, PseudomembranousPharmaceutical SolutionsParatyphoid FeverCephalosporinsNeisseria gonorrhoeaeCross InfectionAnti-Infective Agents, UrinaryNanoparticlesMethylcelluloseSalmonella typhiLaurusMycobacterium tuberculosisBartonella bacilliformisGram-Positive Coccibeta-LactamasesLiposomesCampylobacterMoraxella (Branhamella) catarrhalisGram-Positive Bacterial InfectionsPharmaceutical VehiclesChromatography, Supercritical FluidRespiratory Tract InfectionsOtitis Externa